Was basing it off kyorins pipeline. It's all preclinical and doesn't go into what it even is though.I mean, it makes sense, but would be nice to know what they're going to try that's different.
Thanks FGG, yeah, I realized that a bit later. Makes sense, I was expecting that there was some data they went off of, though. It's probably all confidential right now, though.@WillBeNimble
It's not in Kyorin's pipeline, it's Otonomy's drug. Kyorin are just funding development outside the US (like Astellas is with Frequency). Kyorin has an unrelated anti-inflammatory asthma drug you may be referring to.
Otonomy have said OTO-6xx is a hair cell regeneration drug for severe losses. More info here:
https://investors.otonomy.com/static-files/7422fbf3-e07b-4b71-a398-fb578ab858e1
I read it the opposite. Otonomy are paying Kyorin.It's not in Kyorin's pipeline, it's Otonomy's drug. Kyorin are just funding development outside the US (like Astellas is with Frequency).
I think that this correct. Otonomy has made an agreement with Kyorin to produce and provide the drug to those outside the US and in return Otonomy are given royalties for doing so.I read it the opposite. Otonomy are paying Kyorin.
Great news, whatever the method. The more options the better it is for patients. Eventually something will work, or multiple drugs that are complimentary to each other.It talks about anti-inflammatory and preventing neutrophile migration. How does this generate new hair cells?
Not sure if posted before:
https://hms.harvard.edu/news/dramatic-effect
Here's also a research article of biphosphonates in regards to cochlear synapses by Harvard Medical School: https://www.frontiersin.org/articles/10.3389/fnmol.2020.00087/fullNot sure if posted before:
https://hms.harvard.edu/news/dramatic-effect
Apparently it wasn't doing enough for what they wanted it to do although apparently they got results in some patients.What happend to the Novartis Atoh1 ... what can we read from this?
Last Update was in July 2020
I can't understand what's next or what's the result.
https://clinicaltrials.gov/ct2/show/NCT02132130
Here is the thread on Novartis' drug:What happend to the Novartis Atoh1 ... what can we read from this?
Last Update was in July 2020
I can't understand what's next or what's the result.
https://clinicaltrials.gov/ct2/show/NCT02132130
Some discussion here:Not sure if posted before:
https://hms.harvard.edu/news/dramatic-effect
Nice find.Not sure if posted before:
https://hms.harvard.edu/news/dramatic-effect
Yes, as it states in the article:Interesting. If I am understanding it correctly, it may have an effect on restoring broken synapses between hair cells and the nerve?
Unfortunately, 24 hours is not chronic.Nice find.
The team further suggested that their finding provides possible mechanisms that could explain why some patients in the clinic have improved their ability to recognize speech after bisphosphonate treatment.
So if this bisphosphonate is already in use clinically this clinical trial process can be probably pushed through much faster?
Yes, as it states in the article:
The scientists administered bisphosphonates to mice 24 hours after noise exposure. They found that the medication had a dramatic effect at regenerating the synapses between inner hair cells and spiral ganglion neurons found in the ear, and restoring cochlear function.
I am just wondering if this is for acute or chronic tinnitus.
A previous study analysed data going back 5 years or more and found some evidence that hearing loss stabilised or slightly improved over that time. It wasn't a very rigorous study and I don't have a link to it right now. Sorry.Unfortunately, 24 hours is not chronic.
Yes, but the ones who got treated with this bisphosphonate probably did not get treated for sudden hearing loss with it, so probably it will work also for more chronic cases. Hopefully the BDNF OTO-413 has less side effects and also repairs our synapses.Unfortunately, 24 hours is not chronic.
Interesting, however it seems that this research of looking inside the cochlear has somewhat been done already by other companies such as Frequency Therapeutics. In fact it seems that many of these university based research organisations are well behind when compared to the private companies engaging in research in this sphere, though I could be wrong, and this might be novel.The mechanoreceptive sensory hair cells in the inner ear are selectively vulnerable to numerous genetic and environmental insults. In mammals, hair cells lack regenerative capacity, and their death leads to permanent hearing loss and vestibular dysfunction. Their paucity and inaccessibility has limited the search for otoprotective and regenerative strategies. Growing hair cells in vitro would provide a route to overcome this experimental bottleneck. We report a combination of four transcription factors (Six1, Atoh1, Pou4f3, and Gfi1) that can convert mouse embryonic fibroblasts, adult tail-tip fibroblasts and postnatal supporting cells into induced hair cell-like cells (iHCs). iHCs exhibit hair cell-like morphology, transcriptomic and epigenetic profiles, electrophysiological properties, mechanosensory channel expression, and vulnerability to ototoxin in a high-content phenotypic screening system. Thus, direct reprogramming provides a platform to identify causes and treatments for hair cell loss, and may help identify future gene therapy approaches for restoring hearing
Do you mean that age related hearing loss is not just hair loss, or do you mean that loss is connected to cognitive decline?There is much more to age related hearing loss than hair cell loss alone.
https://www.cell.com/trends/neurosciences/fulltext/S0166-2236(20)30169-7
Unfortunately we keep reading that hearing loss could contribute to cognitive decline.Do you mean that age related hearing loss is not just hair loss, or do you mean that loss is connected to cognitive decline?
Unfortunately we keep reading that hearing loss could contribute to cognitive decline.
I was just looking at the mechanism of age related hearing loss in this publication.
From what I can understand, age related hearing loss is not just hair cell loss. It is much more complicated.
https://hms.harvard.edu/news/upending-dogmaUnfortunately we keep reading that hearing loss could contribute to cognitive decline.
I was just looking at the mechanism of age related hearing loss in this publication.
From what I can understand, age related hearing loss is not just hair cell loss. It is much more complicated.
Indeed. Also I can't remember exactly where I read it but they found that people who live in tribal societies away from the industrialised world displayed significantly better hearing as they aged compared to their counterparts in noisy industrialised societies.https://hms.harvard.edu/news/upending-dogma
Turns out it is by and large just hair cell loss. With new technology, they were able to see the individual hair cells more and identify the losses. The model for human hearing that was made from whatever ancient studies they pulled this dogma from always outpaced the scaled animal odels hearing loss by a large margin. Researchers at the time though couldn't find the cause and just chalked it up to our hearing batteries just being worse. It's really just that we're damaging our ears with how loud everything is.